Nancy J. Hutson - May 19, 2023 Form 4 Insider Report for PhaseBio Pharmaceuticals Inc (PHASQ)

Role
Director
Signature
/s/ Jonathan P. Mow, Attorney-in-fact
Stock symbol
PHASQ
Transactions as of
May 19, 2023
Transactions value $
$0
Form type
4
Date filed
5/19/2023, 04:15 PM
Previous filing
Nov 21, 2022
Next filing
Jun 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHASQ Common Stock Options Exercise +3.75K +11.11% 37.5K May 19, 2023 Direct F1
holding PHASQ Common Stock 4K May 19, 2023 Held in an individual retirement account for the benefit of the Reporting Person

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHASQ Restricted Stock Units Options Exercise $0 -3.75K -100% $0.00* 0 May 19, 2023 Common Stock 3.75K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock.
F2 The RSUs vested and were delivered to the Reporting Person on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service through such date.